Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
d-Amphetamine for Cocaine-Use Disorder
NCT02383043Phase 1Completed
- Start
- Feb 2015
- Primary completion
- Apr 2018
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of adenosine-5′-monophosphate in cocaine use disorder (CUD). Primary endpoint: Number of Times Cocaine Was Selected. Started Feb 2015; status: completed.
02
Drugs
adenosine-5′-monophosphate
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT02383043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02383043.